Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0002021677-24-000001·Calidi Biotherapeutics, Inc.
Schedule 13D ownership disclosure
CALIDI BIOTHERAPEUTICS INC
Common Stock · CUSIP: 320703101
Event date: 2024-05-01
- Filing-level shares
- 3,729,842.00
- Percent of class
- 5.0%
- Kessler Judd SReported CIK 0002021677
Shares: 3,729,842.00 · Class: 5.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002021677-24-000001
- Form type
- SCHEDULE 13D
- Filer
- Calidi Biotherapeutics, Inc.
- CIK
- CIK 1855485
- Filed
- May 01, 2024
- Reporting period
- May 01, 2024
- Description
- Schedule 13D beneficial ownership